Michael Kaseta
Board Member
Heron Therapeutics, Inc. /De/ (HRTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Kaseta
Michael Kaseta is recorded as Board Member at Heron Therapeutics, Inc. /De/ (HRTX). Heron Therapeutics, Inc. /De/ reported in an 8-K filed November 4, 2024 that Michael Kaseta was appointed Director, effective November 4, 2024.
“On November 4, 2024, the Board of Directors (the “Board”) of Heron Therapeutics, Inc. (the “Company”) appointed Michael Kaseta to the Board to serve for a term expiring at the Company’s 2025 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Heron Therapeutics, Inc. /De/
Other people whose current roles at this company are on record from its filings.
- Adam Morgan Chairman, Board Member
- Ira Duarte Chief Accounting Officer, Board Member
- Lisa Peraza Chief Accounting Officer
- Christian Waage Board Member
- Craig Collard Board Member
- Craig Johnson Board Member
- Kevin Kotler Board Member
- Mark Hensley Board Member
- Sharmila Dissanaike Board Member
- Sharmila Dissanaike, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.